About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Astrazeneca Pharma India Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
506820
ISIN Demat
INE203A01020
Book Value
319.60
NSE Code
ASTRAZEN
Dividend Yield %
0.35
Market Cap
225958.75
P/E
113.46
EPS
79.66
Face Value
2
BSE
NSE
29-Dec-2025 15:40
BSE
NSE
NSE F & O
29-Dec-2025 15:31
BSE
NSE
NSE F & O
Last Price
9024.50
Net Change
115.8
% Change
1.3%
Prev.Close
8908.70
Open
8910.50
High
9081.55
Low
8910.50
Volume
686
Last Price
9043.50
Net Change
164.5
% Change
1.85%
Prev.Close
8879.00
Open
8977.00
High
9084.50
Low
8911.00
Volume
8945
Value
6190807
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
9081.55
52-Week High
10653.05
52-Week Low
6301.00
Value
80894107.5
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
9084.50
52-Week High
10691.00
52-Week Low
6312.75
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
03-Sep-18
10-Sep-18
Dividend
1600 %
18-Jul-25
Company News
18-12-2025
AstraZeneca Pharma gets p...
18-12-2025
AstraZeneca Pharma rises ...
18-11-2025
AstraZeneca rises on ente...
17-11-2025
AstraZeneca enters into d...
27-10-2025
AstraZeneca Pharma India...
04-10-2025
Astrazeneca Pharma gets C...
19-09-2025
AstraZeneca Pharma India ...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
